Table 2.
Patient and tumor characteristics, evaluation scores of plastic, breast surgeons and computer
| miniLDF | M + I | BCS | p-value | ||
|---|---|---|---|---|---|
| Age | 46 (25–75) | 45(30–69) | 45(25–61) | 47(26–75) | 0.014* |
| Tumor size (mm) | 17(1–100) | 25(2–60) | 20(2–60) | 15(1–100) | < 0.001* |
| Tumor side | < 0.001# | ||||
| left | 153(44.5%) | 19(50%) | 22(36.7%) | 112(45.5%) | |
| right | 153(44.5%) | 16(42.1%) | 17(28.3%) | 120(48.8%) | |
| bilateral | 38(11%) | 3(7.9%) | 21(35%) | 14(5.7%) | |
| Follow-up Time | 38(6–288) | 62.5(22–123) | 20(8–171) | 36.5(6–288) | < 0.001 |
| Chemotherapy | 0.21# | ||||
| neoadjuvant CT | 57(16.6%) | 4(10.5%) | 14(23.3%) | 39(15.9%) | |
| adjuvant CT | 287(83.4%) | 34(89.5%) | 46(76.7%) | 207(84.1%) | |
| Radiotherapy | < 0.001# | ||||
| no | 48(13.9%) | 1(2.6%) | 34(55.7%) | 13(5.3%) | |
| yes | 297(86.1%) | 37(97.4%) | 27(44.3%) | 233(94.7%) | |
|
JBCS Cosmetic Evaluation Scale (plastic surgeon) |
|||||
| poor | 21(6.1%) | 3(7.9%) | 5(8.3%) | 13(5.3%) | |
| fair | 136(39.7%) | 16(42.1%) | 23(38.3%) | 97(39.6%) | |
| good | 174(50.7%) | 15(39.5%) | 32(53.3%) | 127(51.8%) | |
| excellent | 12(3.5%) | 4(10.5%) | 0 | 8(3.3%) | |
|
JBCS Cosmetic Evaluation Scale (plastic surgeon) |
0.83# | ||||
| poor/fair | 157(45.8%) | 19(50%) | 28(46.7%) | 110(45%) | |
| good/excellent | 186(54.2%) | 19(50%) | 32(53.3%) | 135(55%) | |
|
JBCS Cosmetic Evaluation Scale Score (plastic surgeon) |
8.5(3–12) | 9(2–11) | 9(3–12) | 0.99* | |
|
JBCS Cosmetic Evaluation Scale (breast surgeon) |
|||||
| poor | 19(5.5%) | 3(7.9%) | 6(10%) | 10(4.1%) | |
| fair | 126(36.7%) | 15(39.5%) | 18(30%) | 93(38%) | |
| good | 182(53.1%) | 15(39.5%) | 36(60%) | 131(53.5%) | |
| excellent | 16(4.7%) | 5(13.2%) | 0 | 11(4.5%) | |
|
JBCS Cosmetic Evaluation Scale (breast surgeon) |
0.73# | ||||
| poor/fair | 145(42%) | 18(47.4%) | 24(39.3%) | 103(41.9%) | |
| good/excellent | 200(58%) | 20(52.6%) | 37(60.7%) | 143(58.1%) | |
|
JBCS Cosmetic Evaluation Scale Score (breast surgeon) |
9(3–12) | 9(3–11) | 9(3–12) | 0.98* | |
| BCCT.core Score | 0.43# | ||||
| poor | 22(6.4%) | 2(5.3%) | 5(8.3%) | 15(6.1%) | |
| fair | 110(32.1%) | 15(39.5%) | 13(21.7%) | 82(33.5%) | |
| good | 173(50.4%) | 15(39.5%) | 35(58.3%) | 123(50.2%) | |
| excellent | 38(11.1%) | 6(15.8%) | 7(11.7%) | 25(10.2%) | |
| BCCT.core Score | 0.24# | ||||
| poor/fair | 132(38.3%) | 17(44.7%) | 18(29.5%) | 97(39.4%) | |
| good/excellent | 213(61.7%) | 21(55.3%) | 43(70.5%) | 149(60.6%) |
M + I Mastectomy and Implant, LDF Latissimus Dorsi Flap, BCS Breast-Conserving Surgery
#chi-square test
*Kruskal Wallis test